These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 26607463
1. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats. Arai K, Tsuruoka H, Homma T. Eur J Pharmacol; 2015 Dec 15; 769():266-73. PubMed ID: 26607463 [Abstract] [Full Text] [Related]
2. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, Ishikawa H, Mizuno M, Sada T. Eur J Pharmacol; 2015 Aug 15; 761():226-34. PubMed ID: 26073023 [Abstract] [Full Text] [Related]
3. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats. Arai K, Morikawa Y, Ubukata N, Tsuruoka H, Homma T. J Pharmacol Exp Ther; 2016 Sep 15; 358(3):548-57. PubMed ID: 27384074 [Abstract] [Full Text] [Related]
4. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. Du J, Fan YY, Hitomi H, Kiyomoto H, Kimura S, Kong CZ, Noma T, Kohno M, Nishiyama A, Nakano D. Am J Physiol Renal Physiol; 2009 Sep 15; 297(3):F802-8. PubMed ID: 19535572 [Abstract] [Full Text] [Related]
5. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T. Hypertension; 2006 Jun 15; 47(6):1084-93. PubMed ID: 16636193 [Abstract] [Full Text] [Related]
6. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats. Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T. Nephrol Dial Transplant; 2010 Sep 15; 25(9):2879-89. PubMed ID: 20466668 [Abstract] [Full Text] [Related]
7. Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats. Nariai T, Fujita K, Mori M, Katayama S, Hori S, Matsui K. Pharmacology; 2012 Sep 15; 89(1-2):44-52. PubMed ID: 22302095 [Abstract] [Full Text] [Related]
17. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Huang BS, White RA, Jeng AY, Leenen FH. Am J Physiol Regul Integr Comp Physiol; 2009 Apr 15; 296(4):R994-R1000. PubMed ID: 19118098 [Abstract] [Full Text] [Related]